AI Bias Analysis
4 models · Takes ~15 seconds
Cell and gene therapy makers met in Rome to discuss the field's outlook in Europe. One main topic of conversation: the FDA.
Source
Stat News
Opens original article in a new tab
“They don’t want this kind of scrutiny”: Why Dr. Glaucomflecken is getting involved in protests over an Oregon hospital system’s emergency department.
Policy recommendations in OpenAI's blueprint for unlocking AI’s potential to change health care are reasonable, but also self-serving, experts say.
The psychedelics field is getting what it has long wanted. Now it has to step up.
Ambiguous loss is at the heart of the dementia illness experience.
